- Zeroing in on canine atopic dermatitis
- What makes dogs itch?
- Retrospective evaluation of Apoquel® (oclacitinib) for the treatment of atopic dermatitis. Part 2: monitoring for side effects.
- Apoquel vs. Atopica: a comparison of two medications to control atopic dermatitis in dogs
- Retrospective evaluation of Apoquel® (oclacitinib) for the treatment of 117 dogs with atopic dermatitis. Part 1: control of pruritus (itch).
Learn more about RESPIT
Subscribe to the SkinVet e-Newsletter!
Tag Archives: veterinary dermatology
By Matt Carnett, DVM and Jon Plant, DVM, DACVD There have been a number of advances in canine atopic dermatitis treatment within the past few years, notably the introduction of the janus kinase inhibitor Apoquel (oclacitinib), manufactured by Zoetis. While … Continue reading
Retrospective evaluation of Apoquel® (oclacitinib) for the treatment of atopic dermatitis. Part 2: monitoring for side effects.
By Jon Plant, DVM, DACVD In September I reported on the effectiveness of Apoquel® (oclacitinib) in controlling pruritus (itch) in the first 117 dogs that I had treated with this newish medication from Zoetis. When I prescribe Apoquel, I recommend … Continue reading
You will soon have a new tool for the management of itchy dogs. This is going to be a must-have app for veterinarians who treat allergic dermatitis. Among the features of this iOS app are: Pet parent grading and recording … Continue reading
By Jon Plant, DVM, DACVD Scratching, biting, chewing, rubbing, and excessive licking can all be signs of itch (pruritus) in dogs. A number of methods have been developed to try to quantify itching, but these are most useful in research … Continue reading
By Jon Plant, DVM, DACVD There is a huge demand for Apoquel®, the new Zoetis (NYSE: ZTS) drug for dogs with atopic dermatitis or “allergic” dermatitis. I predict that Apoquel sales will exceed $1 billion per year for Zoetis after … Continue reading
By Jon Plant, DVM, DACVD Bad news, good news about Apoquel® from Zoetis (NYSE: ZTS). We learned last week that the Apoquel backorder situation is likely to continue throughout 2014 and into the summer of 2015. That is very sad … Continue reading
By Jon Plant, DVM, DACVD How much do we know about Apoquel’s safety? Quite a lot, I would argue. The short-term safety profile, based on the data collected during multiple randomized-controlled trials at recommended doses looks good. In a 28-day … Continue reading
By Jon Plant, DVM, DACVD Apoquel® (oclacitinib) is the new Zoetis drug for the treatment of atopic and allergic dermatitis in dogs at least 12 months of age. I’ve been prescribing Apoquel for almost 3 months now and I must … Continue reading
Allergen-specific immunotherapy (ASIT) is frequently used to manage canine atopic dermatitis (AD). The selection of allergens for ASIT is based on intradermal testing (IDT), allergen-specific immunoglobulin E (IgE) assays, patient history, and aerobiological data. In theory, an optimal allergenic extract … Continue reading
RESPIT, regionally-specific immunotherapy, is the practical allergy immunotherapy alternative that you can prescribe for atopic dermatitis in dogs and cats without allergy testing. I recently conducted a survey of all 160 veterinarians who had prescribed RESPIT Injectable prior to September … Continue reading